JPS6323981B2 - - Google Patents
Info
- Publication number
- JPS6323981B2 JPS6323981B2 JP10641880A JP10641880A JPS6323981B2 JP S6323981 B2 JPS6323981 B2 JP S6323981B2 JP 10641880 A JP10641880 A JP 10641880A JP 10641880 A JP10641880 A JP 10641880A JP S6323981 B2 JPS6323981 B2 JP S6323981B2
- Authority
- JP
- Japan
- Prior art keywords
- hydroxymandelic acid
- acid
- hydroxymandelic
- calcium
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- YHXHKYRQLYQUIH-UHFFFAOYSA-N 4-hydroxymandelic acid Chemical compound OC(=O)C(O)C1=CC=C(O)C=C1 YHXHKYRQLYQUIH-UHFFFAOYSA-N 0.000 claims description 33
- 150000003839 salts Chemical class 0.000 claims description 18
- 229910052751 metal Inorganic materials 0.000 claims description 17
- 239000002184 metal Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 9
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 8
- 239000013078 crystal Substances 0.000 claims description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 229910052788 barium Inorganic materials 0.000 claims description 5
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 4
- 239000010949 copper Substances 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229910052749 magnesium Inorganic materials 0.000 claims description 4
- 229910052759 nickel Inorganic materials 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 3
- 150000002739 metals Chemical class 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 8
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 7
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 5
- VKVOJYUPJRVDPP-UHFFFAOYSA-N 2,2-dihydroxy-2-phenylacetic acid Chemical compound OC(=O)C(O)(O)C1=CC=CC=C1 VKVOJYUPJRVDPP-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- -1 copper and barium Chemical class 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- LJCWONGJFPCTTL-UHFFFAOYSA-N 4-hydroxyphenylglycine Chemical compound OC(=O)C(N)C1=CC=C(O)C=C1 LJCWONGJFPCTTL-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 description 3
- 150000004679 hydroxides Chemical class 0.000 description 3
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 2
- TWLSOWAQVSIFIF-UHFFFAOYSA-N 2-hydroxy-2-(2-hydroxyphenyl)acetic acid Chemical compound OC(=O)C(O)C1=CC=CC=C1O TWLSOWAQVSIFIF-UHFFFAOYSA-N 0.000 description 2
- XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1 XQXPVVBIMDBYFF-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 2
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- IWOUKMZUPDVPGQ-UHFFFAOYSA-N barium nitrate Chemical compound [Ba+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O IWOUKMZUPDVPGQ-UHFFFAOYSA-N 0.000 description 2
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 description 2
- 229910000000 metal hydroxide Inorganic materials 0.000 description 2
- 150000004692 metal hydroxides Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YJGSMLNQLMZMJD-UHFFFAOYSA-N 2-(4-aminophenyl)-2-hydroxyacetic acid Chemical compound NC1=CC=C(C(O)C(O)=O)C=C1 YJGSMLNQLMZMJD-UHFFFAOYSA-N 0.000 description 1
- CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 229910021590 Copper(II) bromide Inorganic materials 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- MQRWBMAEBQOWAF-UHFFFAOYSA-N acetic acid;nickel Chemical compound [Ni].CC(O)=O.CC(O)=O MQRWBMAEBQOWAF-UHFFFAOYSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- ITHZDDVSAWDQPZ-UHFFFAOYSA-L barium acetate Chemical compound [Ba+2].CC([O-])=O.CC([O-])=O ITHZDDVSAWDQPZ-UHFFFAOYSA-L 0.000 description 1
- NKQIMNKPSDEDMO-UHFFFAOYSA-L barium bromide Chemical compound [Br-].[Br-].[Ba+2] NKQIMNKPSDEDMO-UHFFFAOYSA-L 0.000 description 1
- 229910001620 barium bromide Inorganic materials 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- UXFOSWFWQAUFFZ-UHFFFAOYSA-L barium(2+);diformate Chemical compound [Ba+2].[O-]C=O.[O-]C=O UXFOSWFWQAUFFZ-UHFFFAOYSA-L 0.000 description 1
- AYJRCSIUFZENHW-DEQYMQKBSA-L barium(2+);oxomethanediolate Chemical compound [Ba+2].[O-][14C]([O-])=O AYJRCSIUFZENHW-DEQYMQKBSA-L 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000004281 calcium formate Substances 0.000 description 1
- 229940044172 calcium formate Drugs 0.000 description 1
- 235000019255 calcium formate Nutrition 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229940095643 calcium hydroxide Drugs 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- MDFUIGCQJJXWBH-UHFFFAOYSA-M calcium magnesium oxygen(2-) chloride Chemical compound [O-2].[Ca+2].[Cl-].[Mg+2] MDFUIGCQJJXWBH-UHFFFAOYSA-M 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229960004841 cefadroxil Drugs 0.000 description 1
- NBFNMSULHIODTC-CYJZLJNKSA-N cefadroxil monohydrate Chemical compound O.C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=C(O)C=C1 NBFNMSULHIODTC-CYJZLJNKSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 1
- HFDWIMBEIXDNQS-UHFFFAOYSA-L copper;diformate Chemical compound [Cu+2].[O-]C=O.[O-]C=O HFDWIMBEIXDNQS-UHFFFAOYSA-L 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 229940076286 cupric acetate Drugs 0.000 description 1
- 229960004643 cupric oxide Drugs 0.000 description 1
- 229940045803 cuprous chloride Drugs 0.000 description 1
- KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical compound [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 description 1
- 229940112669 cuprous oxide Drugs 0.000 description 1
- ZMMDPCMYTCRWFF-UHFFFAOYSA-J dicopper;carbonate;dihydroxide Chemical compound [OH-].[OH-].[Cu+2].[Cu+2].[O-]C([O-])=O ZMMDPCMYTCRWFF-UHFFFAOYSA-J 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 229960000816 magnesium hydroxide Drugs 0.000 description 1
- 235000012254 magnesium hydroxide Nutrition 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229960000869 magnesium oxide Drugs 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- GMDNUWQNDQDBNQ-UHFFFAOYSA-L magnesium;diformate Chemical compound [Mg+2].[O-]C=O.[O-]C=O GMDNUWQNDQDBNQ-UHFFFAOYSA-L 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229940078494 nickel acetate Drugs 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- LGQLOGILCSXPEA-UHFFFAOYSA-L nickel sulfate Chemical compound [Ni+2].[O-]S([O-])(=O)=O LGQLOGILCSXPEA-UHFFFAOYSA-L 0.000 description 1
- UQPSGBZICXWIAG-UHFFFAOYSA-L nickel(2+);dibromide;trihydrate Chemical compound O.O.O.Br[Ni]Br UQPSGBZICXWIAG-UHFFFAOYSA-L 0.000 description 1
- HZPNKQREYVVATQ-UHFFFAOYSA-L nickel(2+);diformate Chemical compound [Ni+2].[O-]C=O.[O-]C=O HZPNKQREYVVATQ-UHFFFAOYSA-L 0.000 description 1
- 229910000008 nickel(II) carbonate Inorganic materials 0.000 description 1
- 229910000363 nickel(II) sulfate Inorganic materials 0.000 description 1
- ZULUUIKRFGGGTL-UHFFFAOYSA-L nickel(ii) carbonate Chemical compound [Ni+2].[O-]C([O-])=O ZULUUIKRFGGGTL-UHFFFAOYSA-L 0.000 description 1
- BFDHFSHZJLFAMC-UHFFFAOYSA-L nickel(ii) hydroxide Chemical compound [OH-].[OH-].[Ni+2] BFDHFSHZJLFAMC-UHFFFAOYSA-L 0.000 description 1
- KBJMLQFLOWQJNF-UHFFFAOYSA-N nickel(ii) nitrate Chemical compound [Ni+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O KBJMLQFLOWQJNF-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 238000005895 oxidative decarboxylation reaction Methods 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- UOURRHZRLGCVDA-UHFFFAOYSA-D pentazinc;dicarbonate;hexahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Zn+2].[Zn+2].[Zn+2].[Zn+2].[Zn+2].[O-]C([O-])=O.[O-]C([O-])=O UOURRHZRLGCVDA-UHFFFAOYSA-D 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 229940102001 zinc bromide Drugs 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- SRWMQSFFRFWREA-UHFFFAOYSA-M zinc formate Chemical compound [Zn+2].[O-]C=O SRWMQSFFRFWREA-UHFFFAOYSA-M 0.000 description 1
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 description 1
- 229940007718 zinc hydroxide Drugs 0.000 description 1
- 229910021511 zinc hydroxide Inorganic materials 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
本発明はp―ヒドロキシマンデル酸の単離方法
に関する。
p―ヒドロキシマンデル酸は種々の医薬品の出
発原料として重要な化合物であり、例えばp―ヒ
ドロキシマンデル酸をアミノ化することにより、
アモキシシリン、セフアドロキシル、セフアトリ
ジンなどのβ―ラクタム系抗生物質の原料である
p―ヒドロキシフエニルグリシンに、還元するこ
とによりp―ヒドロキシフエニル酢酸に、酸化的
脱炭酸することによりp―ヒドロキシベンズアル
デヒドに導くことができ、これらは医薬、農薬、
その他の化成品の極めて重要な中間体である。
p―ヒドロキシマンデル酸の製法としては例え
ばp―ヒドロキシベンズアルデヒドシアンヒドリ
ンを加水分解する方法、p―アミノマンデル酸を
ジアゾ分解する方法、フエノールとグリオキシル
酸とを反応させる方法など、多くの方法が知られ
ている。
しかし、p―ヒドロキシマンデル酸は水溶性が
極めて高いため、せつかく反応が高収率で進行し
ても収率よく単離することが難しく、特にフエノ
ールとグリオキシル酸との反応ではo―ヒドロキ
シマンデル酸(以下「o―体」という)が副生す
るため、p―ヒドロキシマンデル酸を選択的に単
離するには、例えば反応液を弱酸性とし、有機溶
媒でo―体を抽出除去後強酸性とし、有機溶媒で
目的物を抽出して得る必要があるなどp―ヒドロ
キシマンデル酸を選択的に収率よく容易に単離す
ることは困難であつた。そこで本発明者らはp―
ヒドロキシマンデル酸を選択的に収率よく容易に
水性溶媒から単離する方法について種々検討した
結果、p―ヒドロキシマンデル酸のカルシウム、
マグネシウム、亜鉛、ニツケル、銅又はバリウム
などの金属塩が水に対して難溶であり、かつその
溶解度が対応するo―体の金属塩のそれよりも小
さいことを見い出した。
本発明は上記知見をもとに完成されたものであ
る。
即ち、本発明はp―ヒドロキシマンデル酸を含
有する水性溶液にカルシウム、マグネシウム、亜
鉛、ニツケル、銅、及びバリウムからの選択され
る金属の塩、水酸化物又は酸化物を作用させ、析
出したp―ヒドロキシマンデル酸の金属塩結晶を
単離することを特徴とするp―ヒドロキシマンデ
ル酸の単離方法に関する。
本発明方法を実施するにはp―ヒドロキシマン
デル酸を含有する酸性ないし弱塩基性の水性溶液
にカルシウム、マグネシウム、亜鉛、ニツケル、
銅、バリウムなどの金属の塩、水酸化物、酸化物
などを作用させ、析出した結晶を取することに
よつて行われる。水性溶液の溶媒としては水、水
と水に混和する有機溶媒の混合溶媒がよく、、水
に混合する有機溶媒としてはメタノール、エタノ
ール、プロパノールなどの低級アルコール類、ア
セトン、メチルエチルケトンなどのケトン類、テ
トラヒドロフラン、ジオキサンなどのエーテル
類、ジメチルホルムアミド、ジメチルアセトアミ
ド、ジメチルスルホキシド、アセトニトリル、ヘ
キサメチルホスホルアミドなどがあげられる。
p―ヒドロキシマンデル酸を含有する水性溶液
は通常p―ヒドロキシマンデル酸合成の反応液を
そのまま使用するのが好ましく、例えばフエノー
ルとグリオキシル酸とを塩基性水性媒体中で反応
させて得られる反応液などがあげられる。p―ヒ
ドロキシマンデル酸に作用させる金属の塩、水酸
化物、酸化物としては特にその種類、原子価など
は問わない。具体的な代表例としては塩化カルシ
ウム、硝酸カルシウム、炭酸カルシウム、ギ酸カ
ルシウム、酢酸カルシウム、水酸化カルシウム、
酸化カルシウム塩化マグネシウム、臭化マグネシ
ウム、硫酸マグネシウム、硝酸マグネシウム、塩
基性炭酸マグネシウム、ギ酸マグネシウム、酢酸
マグネシウム、水酸化マグネシウム、酸化マグネ
シウム、塩化亜鉛、臭化亜鉛、硫酸亜鉛、硝酸亜
鉛、塩基性炭酸亜鉛、ギ酸亜鉛、酢酸亜鉛、水酸
化亜鉛、酸化亜鉛、塩化ニツケル、臭化ニツケ
ル、硫酸ニツケル、硝酸ニツケル、塩基性炭酸ニ
ツケル、ギ酸ニツケル、酢酸ニツケル、水酸化ニ
ツケル、塩化第一銅、塩化第二銅、臭化第一銅、
臭化第二銅、硫酸第二銅、硝酸第二銅、塩基性炭
酸第二銅、ギ酸第二銅、酢酸第二銅、水酸化第二
銅、酸化第一銅、酸化第二銅、塩化バリウム、臭
化バリウム、硝酸バリウム、炭酸バリウム、ギ酸
バリウム、酢酸バリウム、水酸化バリウム、酸化
バリウム、などおよびそれらの水和物があげられ
る。
p―ヒドロキシマンデル酸に金属の塩を作用さ
せるには、p―ヒドロキシマンデル酸のナトリウ
ム塩、カリウム塩などのアルカリ金属塩又はアン
モニウム塩を含有する水性溶液に金属の塩又はそ
の水性溶液を作用させる方法が好ましい。
p―ヒドロキシマンデル酸に金属の水酸化物、
酸化物を作用させるにはp―ヒドロキシマンデル
酸の水性溶液に金属の水酸化物、酸化物、その水
性溶液又はその水性懸濁液を作用させる方法が好
ましい。
p―ヒドロキシマンデル酸に金属の塩、水酸化
物、酸化物を作用させる温度はその種類、性質な
どにより室温から溶媒の沸点の間で自由に選択す
ることができるが、通常は室温で行うのが好まし
い。又、その時間は通常数分ないし数時間で十分
である。
p―ヒドロキシマンデル酸に対する金属の塩、
水酸化物、酸化物の量は1当量以上であれば特に
制限はないが、1ないし2当量が好ましい。
p―ヒドロキシマンデル酸の金属塩は通常難溶
性結晶として析出し、o―ヒドロキシマンデル酸
は析出しないので、そのまゝ取するか、必要に
応じて、濃縮またはは前述の水に混和する有機溶
媒を加え、析出した結晶を取することにより簡
便かつ高収率で単離することができる。
かくして得られたp―ヒドロキシマンデル酸の
金属塩、例えばカルシウム塩はp―ヒドロキシフ
エニルグリシン、p―ヒドロキシベンズアルデヒ
ドの原料としてそのまま使用することもでき、
又、水に懸濁させ、硫酸、リン酸、シユウ酸又は
それらの水溶性塩などを加えて硫酸塩、リン酸
塩、シユウ酸塩などとしてカルシウムを除去し、
液を濃縮することにより高純度のp―ヒドロキ
シマンデル酸とすることもできる。
次に本発明を実施例により具体的に説明する。
実施例 1
参考例1の方法で製造したp―ヒドロキシマン
デル酸を含有する反応液258.3gに塩化カルシウ
ム14.2g(128mmol)を水30mlに溶かした液を加
え、60―70℃で1時間加熱撹拌し、ついで室温で
一夜放置し、析出した結晶を取し、水洗し60―
70℃で真空乾燥することによりp―ヒドロキシマ
ンデル酸カルシウム塩・1水和物
The present invention relates to a method for isolating p-hydroxymandelic acid. p-Hydroxymandelic acid is an important compound as a starting material for various pharmaceuticals. For example, by aminating p-hydroxymandelic acid,
It is converted into p-hydroxyphenylglycine, which is a raw material for β-lactam antibiotics such as amoxicillin, cephadroxil, and cefatridine, which is converted into p-hydroxyphenylglycine by reduction to p-hydroxyphenylacetic acid, and into p-hydroxybenzaldehyde by oxidative decarboxylation. These include pharmaceuticals, pesticides,
It is an extremely important intermediate for other chemical products. Many methods are known for producing p-hydroxymandelic acid, such as hydrolyzing p-hydroxybenzaldehyde cyanohydrin, diazolyzing p-aminomandelic acid, and reacting phenol with glyoxylic acid. It is being However, since p-hydroxymandelic acid is extremely highly water-soluble, it is difficult to isolate it in a high yield even if the reaction proceeds in a high yield. Since acid (hereinafter referred to as "o-form") is produced as a by-product, in order to selectively isolate p-hydroxymandelic acid, for example, the reaction solution is made weakly acidic, the o-form is extracted and removed with an organic solvent, and then strong acid is added. It has been difficult to selectively and easily isolate p-hydroxymandelic acid in a good yield, as it is necessary to obtain the desired product by extracting it with an organic solvent. Therefore, the present inventors p-
As a result of various studies on methods for selectively and easily isolating hydroxymandelic acid with good yield from an aqueous solvent, we found that calcium of p-hydroxymandelic acid,
It has been found that metal salts such as magnesium, zinc, nickel, copper, or barium are sparingly soluble in water, and their solubility is lower than that of the corresponding o-form metal salts. The present invention was completed based on the above findings. That is, the present invention involves treating an aqueous solution containing p-hydroxymandelic acid with a salt, hydroxide, or oxide of a metal selected from calcium, magnesium, zinc, nickel, copper, and barium, and precipitating p-hydroxymandelic acid. - A method for isolating p-hydroxymandelic acid, which comprises isolating metal salt crystals of hydroxymandelic acid. To carry out the method of the present invention, calcium, magnesium, zinc, nickel,
This is done by treating the salts, hydroxides, oxides, etc. of metals such as copper and barium, and removing the precipitated crystals. The preferred solvent for an aqueous solution is water or a mixed solvent of water and a water-miscible organic solvent. Examples of organic solvents that can be mixed with water include lower alcohols such as methanol, ethanol, and propanol, ketones such as acetone, and methyl ethyl ketone. Examples include ethers such as tetrahydrofuran and dioxane, dimethylformamide, dimethylacetamide, dimethylsulfoxide, acetonitrile, and hexamethylphosphoramide. As the aqueous solution containing p-hydroxymandelic acid, it is usually preferable to use the reaction solution for p-hydroxymandelic acid synthesis as it is, such as a reaction solution obtained by reacting phenol and glyoxylic acid in a basic aqueous medium. can be given. The type and valence of metal salts, hydroxides, and oxides that act on p-hydroxymandelic acid are not particularly limited. Specific typical examples include calcium chloride, calcium nitrate, calcium carbonate, calcium formate, calcium acetate, calcium hydroxide,
Calcium oxide magnesium chloride, magnesium bromide, magnesium sulfate, magnesium nitrate, basic magnesium carbonate, magnesium formate, magnesium acetate, magnesium hydroxide, magnesium oxide, zinc chloride, zinc bromide, zinc sulfate, zinc nitrate, basic zinc carbonate , zinc formate, zinc acetate, zinc hydroxide, zinc oxide, nickel chloride, nickel bromide, nickel sulfate, nickel nitrate, basic nickel carbonate, nickel formate, nickel acetate, nickel hydroxide, cuprous chloride, second chloride copper, cuprous bromide,
Cupric bromide, cupric sulfate, cupric nitrate, basic cupric carbonate, cupric formate, cupric acetate, cupric hydroxide, cuprous oxide, cupric oxide, chloride Examples include barium, barium bromide, barium nitrate, barium carbonate, barium formate, barium acetate, barium hydroxide, barium oxide, and hydrates thereof. In order to cause a metal salt to act on p-hydroxymandelic acid, the metal salt or its aqueous solution is allowed to act on an aqueous solution containing an alkali metal salt such as sodium salt or potassium salt or ammonium salt of p-hydroxymandelic acid. The method is preferred. Metal hydroxide in p-hydroxymandelic acid,
In order to cause the oxide to act, it is preferable to use a method in which a metal hydroxide, oxide, an aqueous solution thereof, or an aqueous suspension thereof is made to act on an aqueous solution of p-hydroxymandelic acid. The temperature at which metal salts, hydroxides, and oxides are applied to p-hydroxymandelic acid can be freely selected between room temperature and the boiling point of the solvent depending on the type and properties of the metal, but it is usually carried out at room temperature. is preferred. Further, the time required for this is usually several minutes to several hours. metal salts for p-hydroxymandelic acid;
The amount of hydroxide and oxide is not particularly limited as long as it is 1 equivalent or more, but 1 to 2 equivalents are preferred. Metal salts of p-hydroxymandelic acid usually precipitate as poorly soluble crystals, while o-hydroxymandelic acid does not precipitate, so it can be taken as is or, if necessary, concentrated or mixed with the aforementioned water-mixed organic solvent. It can be isolated easily and in high yield by adding 100% and collecting the precipitated crystals. The metal salt of p-hydroxymandelic acid, such as a calcium salt, obtained in this way can be used as it is as a raw material for p-hydroxyphenylglycine and p-hydroxybenzaldehyde.
Alternatively, calcium is removed by suspending it in water and adding sulfuric acid, phosphoric acid, oxalic acid, or their water-soluble salts as sulfate, phosphate, oxalate, etc.
High purity p-hydroxymandelic acid can also be obtained by concentrating the liquid. Next, the present invention will be specifically explained using examples. Example 1 A solution of 14.2 g (128 mmol) of calcium chloride dissolved in 30 ml of water was added to 258.3 g of the reaction solution containing p-hydroxymandelic acid produced by the method of Reference Example 1, and the mixture was heated and stirred at 60-70°C for 1 hour. Then, leave it at room temperature overnight, remove the precipitated crystals, wash with water, and leave for 60 minutes.
p-hydroxymandelic acid calcium salt monohydrate by vacuum drying at 70℃
【式】39.7g
(収率67.5%、回収率95.7%)を得た。
ここで回収率とは、取り出した塩中のp―ヒド
ロキシマンデル酸のモル数を反応液中に生成して
いたp―ヒドロキシマンデル酸のモル数で除し、
これに100を乗じた値である。この粗生成物はo
―ヒドロキシマンデル酸0.30g及びフエノールと
2分子のグリオキシル酸の縮合体0.70gを含有す
る以外、他の不純物は含まなかつた。構造決定
は、この粗結晶の一部をとり、水に懸濁し、室温
で撹拌後取することにより精製した結晶中のp
―ヒドロキシマンデル酸の含有率(高速液体クロ
マトグラフイーによつて定量)、水分の含有率
(カールフイツシヤー法による測定)、及びカルシ
ウムの含有率(EDTAを用いる定量)を測定す
ることにより行つた。結果は次の通りである。[Formula] 39.7g (yield: 67.5%, recovery rate: 95.7%) was obtained. Here, the recovery rate is calculated by dividing the number of moles of p-hydroxymandelic acid in the extracted salt by the number of moles of p-hydroxymandelic acid produced in the reaction solution.
This is the value multiplied by 100. This crude product is o
- Contains no other impurities except for 0.30 g of hydroxymandelic acid and 0.70 g of a condensate of phenol and two molecules of glyoxylic acid. Structure determination was carried out by taking a part of this crude crystal, suspending it in water, stirring it at room temperature, and collecting it.
-Conducted by measuring the content of hydroxymandelic acid (determined by high performance liquid chromatography), the content of water (determined by Karl Fischer method), and the content of calcium (determined by EDTA) . The results are as follows.
【表】
実施例 2―13
参考例1の方法で製造したp―ヒドロキシマン
デル酸を含有する反応液258.2gに水を加えて
300.0gとし、これより20g(p―ヒドロキシマ
ンデル酸2.37g(14.1mmol)を含有する)を取
りこれに表1に示した金属塩8.8ミリモルを加え、
必要に応じて塩酸でPHを調整し室温で3時間撹拌
したのち、析出した結晶を取し、水洗し、60―
70℃で真空乾燥することにより、p―ヒドロキシ
マンデル酸の金属塩を得た。[Table] Example 2-13 Water was added to 258.2 g of the reaction solution containing p-hydroxymandelic acid produced by the method of Reference Example 1.
300.0 g, from which 20 g (containing 2.37 g (14.1 mmol) of p-hydroxymandelic acid) was added, and 8.8 mmol of the metal salt shown in Table 1 was added thereto.
After adjusting the pH with hydrochloric acid as necessary and stirring at room temperature for 3 hours, the precipitated crystals were collected, washed with water, and 60-
A metal salt of p-hydroxymandelic acid was obtained by vacuum drying at 70°C.
【表】
参考例 1
フエノール84.6g(900mmol)と水200mlの懸
濁液に40%水酸化ナトリウム水溶液を加えてPHを
10.5とする。この溶液に40%グリオキシル酸水溶
液111.1g(600mmol)、水200mlおよび40%水酸
化ナトリウム水溶液でPHを10.5とした溶液を加
え、室温で24時間反応させる。この反応液に濃塩
酸を加えてPHを5とし、1,1,2,2―テトラ
クロルエタン140mlで3回残存フエノールを抽出
除去した後水層を全量516.5gまで減圧濃縮する。
この溶液中には高速液体クロマトグラフイーに
よる定量でp―ヒドロキシマンデル酸71.1g
(423mmol)、o―ヒドロキシマンデル酸10.5g
(62.4mmol)、フエノールと2分子のグリオキシ
ル酸の縮合体18.2g(75.2mmol)フエノール2.3
g(24.4mmol)及び微量の副反応生成物を含有
することが判明した。[Table] Reference example 1 Add 40% aqueous sodium hydroxide solution to a suspension of 84.6 g (900 mmol) of phenol and 200 ml of water to adjust the pH.
10.5. To this solution, 111.1 g (600 mmol) of a 40% glyoxylic acid aqueous solution, 200 ml of water, and a solution whose pH was adjusted to 10.5 with a 40% aqueous sodium hydroxide solution were added, and the mixture was allowed to react at room temperature for 24 hours. Concentrated hydrochloric acid was added to this reaction solution to adjust the pH to 5, and residual phenol was extracted and removed three times with 140 ml of 1,1,2,2-tetrachloroethane, and the aqueous layer was concentrated under reduced pressure to a total amount of 516.5 g. This solution contained 71.1 g of p-hydroxymandelic acid as determined by high performance liquid chromatography.
(423mmol), o-hydroxymandelic acid 10.5g
(62.4 mmol), condensate of phenol and 2 molecules of glyoxylic acid 18.2 g (75.2 mmol) phenol 2.3
g (24.4 mmol) and trace amounts of side reaction products.
Claims (1)
液にカルシウム、マグネシウム、亜鉛、ニツケ
ル、銅、及びバリウムから選択される金属の塩、
水酸化物又は酸化物を作用させ、析出したp―ヒ
ドロキシマンデル酸の金属塩結晶を単離すること
を特徴とするp―ヒドロキシマンデル酸の単離方
法。1 salts of metals selected from calcium, magnesium, zinc, nickel, copper, and barium in an aqueous solution containing p-hydroxymandelic acid;
A method for isolating p-hydroxymandelic acid, which comprises isolating metal salt crystals of p-hydroxymandelic acid precipitated by the action of a hydroxide or oxide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10641880A JPS5745134A (en) | 1980-08-04 | 1980-08-04 | Isolation of p-hydroxymandelic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10641880A JPS5745134A (en) | 1980-08-04 | 1980-08-04 | Isolation of p-hydroxymandelic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5745134A JPS5745134A (en) | 1982-03-13 |
JPS6323981B2 true JPS6323981B2 (en) | 1988-05-18 |
Family
ID=14433113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10641880A Granted JPS5745134A (en) | 1980-08-04 | 1980-08-04 | Isolation of p-hydroxymandelic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5745134A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0560285U (en) * | 1992-01-22 | 1993-08-10 | 昭和鋼機株式会社 | Animal capture device |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2901553B1 (en) * | 2006-05-24 | 2011-08-26 | Clariant Specialty Fine Chem F | METAL COMPLEX COMPRISING A 2-ARYL-2-HYDROXYACETIC ACID-DERIVED LIGAND AND A DIVALENT OR TRIVALENT METAL CATION, AND USE THEREOF |
-
1980
- 1980-08-04 JP JP10641880A patent/JPS5745134A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0560285U (en) * | 1992-01-22 | 1993-08-10 | 昭和鋼機株式会社 | Animal capture device |
Also Published As
Publication number | Publication date |
---|---|
JPS5745134A (en) | 1982-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114605328A (en) | Preparation method of 6-chloro-2-methyl-2H-indazole-5-amine | |
US4198526A (en) | Process for the manufacture of p-hydroxyphenyl acetic acid | |
JPS6323981B2 (en) | ||
JPS6222740A (en) | Isolation of p-hydroxybenzaldehyde | |
US3059030A (en) | Diketocyclobutenediol and alkali metal salts thereof | |
US6570022B2 (en) | Preparation of bis-(1(2)H-tetrazol-5-yl)-amine monohydrate | |
GB2548301B (en) | Method for producing nitrogen-containing pentafluorosulfanylbenzene compound | |
EP0038656B1 (en) | An improved process for the manufacture of p-hydroxybenzyl cyanide | |
JPS60258143A (en) | Production of 2,3,5,6-tetrafluorobenzoic acid | |
JPH0564940B2 (en) | ||
US4205185A (en) | Process for preparing racemic 4-hydroxyphenylglycine | |
US5395943A (en) | Method for purification of 2-alkyl-4-halo-5-formylimidazoles | |
JPS6357574A (en) | Production of imidazoles | |
JP3082006B2 (en) | Method for producing 2-alkylthio-4,6-dihydroxypyrimidine | |
JP4221770B2 (en) | Process for producing isoquinoline lysate compound | |
JPS6354705B2 (en) | ||
JP3924027B2 (en) | Sodium orthohydroxymandelate / phenol / water complex, process for its preparation and use for the separation of sodium orthohydroxymandelate | |
JPH0410450B2 (en) | ||
JP3986065B2 (en) | Cinnamaldehyde compounds having a novel azide group | |
JP4207270B2 (en) | Method for producing alkyl cyanobenzoate | |
JP3026037B2 (en) | Purification method of α-hydroxy-3,4-dihydroxyphenylacetic acids | |
JP4587139B2 (en) | A method for producing an aminoalkoxycarbostyril derivative. | |
JPS61172846A (en) | Method of optical resolution of (+-)-2-chloroprorionic acid | |
JPS59130246A (en) | Production of beta-hydroxy-aminoacid | |
CN116987024A (en) | Preparation method of atazanavir intermediate |